A Case of Psoriasis Vulgaris Treated with Brodalumab in a Hemodialysis Patient with End-Stage Renal Disease due to Diabetic Nephropathy

Figure 2

(a, b) Almost complete clearance of psoriatic lesions at 12 weeks after the start of brodalumab treatment.

(a)

(b)